Cbz-NH-PEG12-C2-acid
CAS No. 1334177-88-6
Cbz-NH-PEG12-C2-acid( —— )
Catalog No. M26935 CAS No. 1334177-88-6
Cbz-NH-PEG12-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 48 | Get Quote |
|
10MG | 68 | Get Quote |
|
25MG | 107 | Get Quote |
|
50MG | 158 | Get Quote |
|
100MG | 233 | Get Quote |
|
200MG | 332 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCbz-NH-PEG12-C2-acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionCbz-NH-PEG12-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
-
DescriptionCbz-NH-PEG12-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAMPK| Glucokinase| PPARα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1334177-88-6
-
Formula Weight751.864
-
Molecular FormulaC35H61NO16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)OCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Camellianin A
Camellianin A has anticancer activity, it can inhibit the proliferation of the human hepatocellular liver carcinoma Hep G2 and human breast adenocarcinoma MCF-7 cell lines in a dose-dependent manner and induce the significant increase of the G0/G1 cell population.
-
Docosahexaenoic Acid
Docosahexaenoic Acid (DHA) is an essential fatty acid and an omega-3 fatty acid abundant in brain and retina.
-
Carbaglu
Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.